SCHEMBL22200566

SCHEMBL22200566

CSc1ncc2cc(-c3ccc(NSCc4ccccc4F)c(F)c3)c(=O)n(C(C)C)c2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 2/20 0.40
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
BTK Q06187 1/20 0.36
MAPT P10636 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
SRC P12931 3/20 0.33
ABL1 P00519 2/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
WEE1 P30291 2/20 0.33
ALOX5AP P20292 2/20 0.32
FEN1 P39748 2/20 0.32
F10 P00742 1/20 0.32
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32
POLB P06746 1/20 0.31
MAPK14 Q16539 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22200391 0.94 ERN1 (0.35) ERN1TSHRHTTBTKMAPT
SCHEMBL22200559 0.90 ERN1 (0.40) ERN1TSHRHTTBTKSRC
SCHEMBL29356139 0.85 ERN1 (0.49) ERN1ALOX5APFEN1
SCHEMBL22190892 0.85 ERN1 (0.49) ERN1ALOX5APFEN1
SCHEMBL22200440 0.85 ALDH1A1 (0.42) ERN1TSHRHTTBTKSRC
SCHEMBL22200407 0.84 ERN1 (0.40) ERN1BTKMAPTRXFP1PIK3CA
SCHEMBL22200564 0.83 ERN1 (0.39) ERN1TSHRHTTBTKMAPT
SCHEMBL22200758 0.83 BRAF (0.39) ERN1TSHRHTTSRCABL1
SCHEMBL22190691 0.80 ERN1 (0.44) ERN1ALOX5APFEN1
SCHEMBL29354823 0.80 ERN1 (0.44) ERN1ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020142612-A1 PYRIDO-PYRIMIDINONE AND PTERIDINONE COMPOUNDS AS INHIBITORS OF ENDORIBONUCLEASE INOSITOL REQUIRING ENZYME I (IRE I ALPHA) FOR THE TREATMENT OF CANCER DISEASES. GENENTECH, INC. (US) 2020-07-09 WO disclosed